CVS Health Corporation [NYSE: CVS] jumped around 0.04 points on Monday, while shares priced at $69.42 at the close of the session, up 0.06%. The company report on May 16, 2023 at 10:00 AM that Virginia Community Health Centers and Aetna Better Health Virginia team-up to improve cancer outcomes in under-resourced communities.
Aetna Better Health of Virginia, a CVS Health company (NYSE: CVS), and Virginia Community Healthcare Association (VCHA) announced that Aetna provided a total of $7.3 million in value-based care incentive payments to 22 Federally Qualified Health Centers, also known as Community Health Centers, in Virginia. The funds aim to help health centers improve quality of care by enabling their population health management programs and increasing screenings for diabetes as well as breast, cervical and colon cancers.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
“Harmful disparities exist in health outcomes among minorities, the poor and those who live in rural communities,” says Tracy Douglas, CEO of Virginia Community Healthcare Association. “Those disparities, often related to social determinants of health, lead to suffering and death in patients, despite many having received intervention from our health centers. When VCHA learned that Aetna shared our desire to address these challenges, we saw an opportunity to facilitate conversations with our membership. As a result, most of our member health centers secured funds to bolster their capabilities to drive quality outcomes.”.
CVS Health Corporation stock is now -25.51% down from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $69.85 and lowest of $68.71 per share. The company’s 52-week high price is 107.26, which means current price is +3.53% above from all time high which was touched on 01/04/23.
Compared to the average trading volume of 8.45M shares, CVS reached a trading volume of 7380538 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about CVS Health Corporation [CVS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $100.95 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for CVS Health Corporation is set at 1.41, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.27. The Price to Book ratio for the last quarter was 1.25, with the Price to Cash per share for the same quarter was set at 13.84. Price to Free Cash Flow for CVS in the course of the last twelve months was 6.15 with Quick ratio for the last quarter at 0.70.
How has CVS stock performed recently?
CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.83. With this latest performance, CVS shares dropped by -4.70% in over the last four-week period, additionally sinking by -26.87% over the last 6 months – not to mention a drop of -25.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 41.51, with the RSI for the last a single of trading hit 44.39, and the three-weeks RSI is set at 39.99 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 73.13, while it was recorded at 68.93 for the last single week of trading, and 89.34 for the last 200 days.
CVS Health Corporation [CVS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.08 and a Gross Margin at +16.92. CVS Health Corporation’s Net Margin is presently recorded at +1.29.
Return on Total Capital for CVS is now 11.18, given the latest momentum, and Return on Invested Capital for the company is 2.93. Return on Equity for this stock inclined to 5.68, with Return on Assets sitting at 1.74. When it comes to the capital structure of this company, CVS Health Corporation [CVS] has a Total Debt to Total Equity ratio set at 99.60. Additionally, CVS Total Debt to Total Capital is recorded at 49.90, with Total Debt to Total Assets ending up at 29.94. Long-Term Debt to Equity for the company is recorded at 94.73, with the Long-Term Debt to Total Capital now at 47.46.
Reflecting on the efficiency of the workforce at the company, CVS Health Corporation [CVS] managed to generate an average of $13,830 per employee. Receivables Turnover for the company is 12.49 with a Total Asset Turnover recorded at a value of 1.35.CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.
Earnings analysis for CVS Health Corporation [CVS]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 4.00%.